Can-Fite BioPharma Ltd. (NYSE American: CANF) Featured in Virtual Coverage of Benzinga’s Global Small Cap Conference
Can-Fite BioPharma Ltd. (NYSE American: CANF) isanadvanced clinical stage drug development company with a novel therapeutic approach for the treatment of liver and inflammatory diseases, addressing multi-billion dollar markets. Oral drugs with proven safety and efficacy - Piclidenoson and Namodenoson are Phase III assets in psoriasis and liver cancer and Namodenoson showed strong efficacy in a Phase II NASH study. Piclidenoson has recently been approved…